Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2007
09/07/2007WO2007068434A3 Medicament based on a monoester of steroids with long chain fatty acids
09/07/2007WO2007054514A3 Use of pde iii inhibitors or calcium sensitizers for the treatment of asymptomatic (occult) heart failure
09/07/2007WO2007022173A3 Crystalline forms fenoldopam mesylate
09/07/2007WO2007011760A3 Inhibitors of mitotic kinesin
09/07/2007WO2006079217A8 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis
09/07/2007WO2002075302A8 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal
09/07/2007CA2645123A1 Use of dha and ara in the preparation of a composition for regulating gene expression
09/07/2007CA2644933A1 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
09/07/2007CA2644578A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors
09/07/2007CA2643723A1 Cathepsin propeptide and uses thereof
09/07/2007CA2643492A1 Nanoparticulate carvedilol formulations
09/07/2007CA2643320A1 Modulators of muscarinic receptors
09/07/2007CA2642424A1 Primary amines as renin inhibitors
09/07/2007CA2642368A1 Treatment of prevention of valvular heart disease with flibanserin
09/07/2007CA2640754A1 Pyrazole derivatives as sigma receptors antagonists
09/06/2007US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
09/06/2007US20070208077 Adiponectin Enhancer
09/06/2007US20070208066 ER-beta-selective ligands
09/06/2007US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators
09/06/2007US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/06/2007US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
09/06/2007US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity
09/06/2007US20070207978 Stimulate mammalian coronary vasodilatation; imaging the heart; antiinflammatory; adjunctive therapy with angioplasty; platelet aggregation inhibitor; inhibitor of platelet and neutrophil activation;
09/06/2007US20070207943 Interleukins-21 and 22
09/06/2007US20070207523 Mammalian t-type calcium channels
09/06/2007US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
09/06/2007DE102006008880A1 Aminopyrimidinderivate Aminopyrimidine derivatives
09/05/2007EP1829962A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
09/05/2007EP1829961A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
09/05/2007EP1829888A1 Anti-inflammatory compounds and uses thereof
09/05/2007EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
09/05/2007EP1829876A1 Nitrogeneous tricyclic compound
09/05/2007EP1829873A1 Pyrrazole derivatives as sigma receptors antagonists
09/05/2007EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof
09/05/2007EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome
09/05/2007EP1829542A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same
09/05/2007EP1829535A2 Tissue factor antagonists and methods of use thereof
09/05/2007EP1829529A1 Controlled release compositions of estradiol metabolites
09/05/2007EP1828248A2 Compositions comprising anti-igf-1 receptor antibodies and methods for obtaining said antibodies
09/05/2007EP1828186A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
09/05/2007EP1828135A2 Compounds and compositions as modulators of steroidal receptors and calcium channel activities
09/05/2007EP1828118A1 Parp inhibitors
09/05/2007EP1828109A2 Guanidine derivatives as inhibitors of ddah
09/05/2007EP1827474A2 Heat shock proteins (hsp) and supraventricular arrhythmia
09/05/2007EP1827472A2 Methods for improving the structure and function of arterioles
09/05/2007EP1827448A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors
09/05/2007EP1827440A1 Method for reduction, stabilization and prevention of rupture of lipid rich plaque
09/05/2007EP1827425A1 Use of ppar agonists for the treatment of congestive heart failure
09/05/2007EP1827424A1 Combination therapy comprising telmisartan and hydrochlorothiazide
09/05/2007EP1827410A2 Bis(thio-hydrazide amides) for increasing hsp70 expression
09/05/2007EP1827384A1 Directly pressed indapamide tablets with delayed release of the active substance
09/05/2007EP1827298A2 Therapeutic adjuncts to enhance the organ protective effects of postconditioning
09/05/2007EP1511507B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
09/05/2007EP1505967A4 Method for treating obesity
09/05/2007EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
09/05/2007EP1406892B1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007EP1345598B1 The use of rosiglitazone for treating psychiatric disorders.
09/05/2007EP1267917B1 Angiogenic onchocerca volvulus proteins and uses thereof
09/05/2007EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
09/05/2007EP1036566B1 Preparation for continuous intravenous administration
09/05/2007EP0757716B1 Dna encoding bradykinin b1 receptor
09/05/2007CN101031566A Proline derivatives
09/05/2007CN101031563A Benzimidazole derivatives, composition containing thereof and its preparation and application
09/05/2007CN101031562A Imidazole-5-carboxylic acid derivative, its production and use
09/05/2007CN101031561A Carbonyl compounds used as coagulation factor xa inhibitor
09/05/2007CN101031549A 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
09/05/2007CN101031302A Methods for treating a mammal before, during and after cardiac arrest
09/05/2007CN101029080A Methods and compositions for derepression of IAP-inhibited caspase
09/05/2007CN101029051A (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor
09/05/2007CN101029048A Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone
09/05/2007CN101029037A 2-benzo(C) foroxone compound, its production and use
09/05/2007CN101028538A Medical devices containing rapamycin analogs
09/05/2007CN101028518A Medicinal composition containing silver ester medicine and ibobulodine
09/05/2007CN101028517A Composition containing ADP receptor antagonist and silver ester medicine
09/05/2007CN101028503A Oral Chinese-medicine composition for treating Raynaud's disease
09/05/2007CN101028499A Oral Chinese medicine for treating low-fever febrifuge viral myocarditis
09/05/2007CN101028498A Oral Chinese medicine for treating cough rheumatic heart disease
09/05/2007CN101028497A Oral Chinese medicine for treating lower-limb turgescene rheumatic heart diease
09/05/2007CN101028486A Oral Chinese medicinal composition for treating apoplexia
09/05/2007CN101028483A Oral Chinese medicine for treating Qi-stagnation viral myocarditis
09/05/2007CN101028458A Tongluo Futan preparation
09/05/2007CN101028452A Aloe oral tablet and its production
09/05/2007CN101028450A Medicinal composition for treating cardica cerebrovascular diseases
09/05/2007CN101028449A Medicine liquor for treating hypertension
09/05/2007CN101028437A Chinese-medicinal effective part composition for preventing cardiovascular disease and its production
09/05/2007CN101028434A Oral Chinese medicine for treating rheumatic heart disease
09/05/2007CN101028433A Oral Chinese medicine for treating blood-vessel obstructive rheumatic heart disease
09/05/2007CN101028432A Oral Chinese medicine for treating Qi-deficiency viral myocarditis
09/05/2007CN101028431A Oral Chinese medicine for treating both Qi and blood deficiency rheumatic heart disease
09/05/2007CN101028430A Oral Chinese medicine for treating Yang-deficiency rheumatic heart disease
09/05/2007CN101028416A Chinese-medicinal composition for treating coronary heart disease
09/05/2007CN101028415A Oral Chinese medicine for treating phlegm-heat obstructive rheumatic heart disease
09/05/2007CN101028396A Oral Chinese-medicinal composition for treating apoplexia
09/05/2007CN101028367A Tongshuan Huoluo preparation
09/05/2007CN101028359A Oral Chinese medicinal composition for treating hypertension
09/05/2007CN101028351A Oral Chinese medicine for treating spleen insufficiency rheumatic heart disease
09/05/2007CN101028346A Use of Japanese Polygala in preparation of medicine for treating diarrhea
09/05/2007CN101028341A Magnoliaceae plant extract, its production and use